Literature DB >> 17028302

MicroRNAs in biological processes and carcinogenesis.

Hirotaka Osada1, Takashi Takahashi.   

Abstract

MicroRNAs (miRNAs) encoding small non-coding RNAs have been recognized as a very large gene family present in most organisms. The precise biological effects of miRNAs are yet to be elucidated in detail, partly because each miRNA is believed to negatively regulate the expression of hundreds of target genes. Nevertheless, recent findings indicate that carcinogenic processes are associated with alterations in the expression of several miRNAs, suggesting that some function as oncogenes or tumor suppressor genes. The present review focuses on recent findings in this exciting new area of research, with special emphasis on the involvement of miRNAs in cancer development and progression. Further studies are clearly warranted to elucidate the molecular and biological roles of miRNAs, which may ultimately provide both a better understanding of disease development, as well as a foundation for novel strategies for cancer diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028302     DOI: 10.1093/carcin/bgl185

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  105 in total

Review 1.  MicroRNAs in liver disease.

Authors:  Xin Wei Wang; Niels H H Heegaard; Henrik Orum
Journal:  Gastroenterology       Date:  2012-04-11       Impact factor: 22.682

2.  miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo.

Authors:  Deena M Leslie Pedrioli; Terhi Karpanen; Vasilios Dabouras; Giorgia Jurisic; Glenn van de Hoek; Jay W Shin; Daniela Marino; Roland E Kälin; Sebastian Leidel; Paolo Cinelli; Stefan Schulte-Merker; André W Brändli; Michael Detmar
Journal:  Mol Cell Biol       Date:  2010-05-17       Impact factor: 4.272

3.  MiR-143 targets CTGF and exerts tumor-suppressing functions in epithelial ovarian cancer.

Authors:  Lufei Wang; Jin He; Hongmei Xu; Longjie Xu; Na Li
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

4.  miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels.

Authors:  Kotb Abdelmohsen; Subramanya Srikantan; Yuki Kuwano; Myriam Gorospe
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

5.  MicroRNA-103-1 selectively downregulates brain NCX1 and its inhibition by anti-miRNA ameliorates stroke damage and neurological deficits.

Authors:  Antonio Vinciguerra; Luigi Formisano; Pierpaolo Cerullo; Natascia Guida; Ornella Cuomo; Alba Esposito; Gianfranco Di Renzo; Lucio Annunziato; Giuseppe Pignataro
Journal:  Mol Ther       Date:  2014-06-23       Impact factor: 11.454

6.  Dietary methyl deficiency, microRNA expression and susceptibility to liver carcinogenesis.

Authors:  Athena Starlard-Davenport; Volodymyr Tryndyak; Oksana Kosyk; Sharon R Ross; Ivan Rusyn; Frederick A Beland; Igor P Pogribny
Journal:  J Nutrigenet Nutrigenomics       Date:  2011-04-06

7.  Radiation modulation of microRNA in prostate cancer cell lines.

Authors:  Sajni Josson; Shian-Ying Sung; Kaiqin Lao; Leland W K Chung; Peter A S Johnstone
Journal:  Prostate       Date:  2008-11-01       Impact factor: 4.104

8.  miRNA and piRNA localization in the male mammalian meiotic nucleus.

Authors:  E Marcon; T Babak; G Chua; T Hughes; P B Moens
Journal:  Chromosome Res       Date:  2008-01-22       Impact factor: 5.239

9.  MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network.

Authors:  Jianjun Zhang; Haiyan Guo; Guanxiang Qian; Shengfang Ge; Huifeng Ji; Xiaobo Hu; Wantao Chen
Journal:  Mol Cancer       Date:  2010-08-06       Impact factor: 27.401

10.  Estrogen Regulation of MicroRNA Expression.

Authors:  Carolyn M Klinge
Journal:  Curr Genomics       Date:  2009-05       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.